poisar

Stocks · News reference

Jones Trading Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $32

Benzinga Newsdesk

Jones Trading analyst Justin Walsh initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Buy rating and announces Price Target of $32.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

SPTX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  3. Benzinga Newsdesk

    Seaport Therapeutics Q2 EPS $(1.78) Misses $(0.65) Estimate

    Seaport Therapeutics (NASDAQ:SPTX) reported quarterly losses of $(1.78) per share which missed the analyst consensus estimate of $(0.65) by 173.85 percent. This is a 72.19 percent increase over losses of $(6.40) per

    SPTX